FCM
AMGN icon

Fieldview Capital Management’s Amgen AMGN Stock Holding History

Fieldview Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,694
Closed -$1.59M – 391
2025
Q2 		$1.59M Buy
+5,694
New +$1.61M 0.24% 149
2025
Q1 		– Sell
-25,555
Closed -$6.66M – 404
2024
Q4 		$6.66M Buy
+25,555
New +$7.58M 1.03% 11

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fieldview Capital Management's AMGN Position: Q3 2025 in Review

Fieldview Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 5,694 shares — an estimated $1.59M sold.

Fieldview Capital Management first reported a position in AMGN in Q4 2024 and held it in 2 quarters. The position peaked at $6.66M in Q4 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Fieldview Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 5,694 Amgen shares in Q3 2025, an estimated $1.59M.
  • Fieldview Capital Management first reported a position in Amgen in Q4 2024 and held it in 2 quarters.
  • Fieldview Capital Management's Amgen position peaked at $6.66M in Q4 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Fieldview Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.